Indication

Hematopoietic syndrome of acute radiation syndrome

Hematopoietic syndrome of acute radiation syndrome is a life-threatening, dose-dependent clinical sub-syndrome caused by high-dose, penetrating ionizing radiation delivered to the whole body or a significant portion of it over a short duration. Read more about Hematopoietic syndrome of acute radiation syndrome

26 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Hematopoietic syndrome of acute radiation syndrome therapies.

Showing 10–18 of 26 drugs

Filter & compare in the drug finder →Opens the drug finder with Hematopoietic syndrome of acute radiation syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hematopoietic syndrome of acute radiation syndrome.

Hematopoietic syndrome of acute radiation syndrome is a life-threatening, dose-dependent clinical sub-syndrome caused by high-dose, penetrating ionizing radiation delivered to the whole body or a significant portion of it over a short duration.

It primarily targets the hematopoietic system, driven pathophysiologically by the profound depletion and mitotic arrest of radiosensitive bone marrow hematopoietic stem and progenitor cells.

This myelosuppression results in severe pancytopenia characterized by profound lymphopenia, neutropenia, and thrombocytopenia, which typically manifests weeks after exposure with life-threatening infections, sepsis, spontaneous hemorrhage, and impaired wound healing.

Personalize your experience

Follow Hematopoietic syndrome of acute radiation syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it